abstract |
The present invention is the treatment of autonomic neurological disorders using Clostridium neurotoxin comprising H CC domains from BoNT/B, BoNT/D, BoNT/DC, BoNT/F or BoNT/G, wherein the clos administered to a patient The dose of tridium neurotoxin relates to treatment that is equivalent to or lower than the dose of BoNT/A used to treat the same autonomic disorder. |